HMGBiotech is a biotech company that provides reagents, services and ideas to researchers and companies active in the HMGB field.
The only producer of quality-controlled redox variants of HMGB1
High Mobility Group Box 1 (HMGB1), also known as HMG-1 or amphoterin, is a highly conserved nuclear protein encoded by the HMGB1 gene. As a member of the high mobility group family, HMGB1 contains a characteristic HMG-box domain, which enables its interaction with DNA and other nuclear components.
Featured news
World Kidney Day, occurred on March 13th, raises awareness of the important of kidney related researches and therapeutic strategies to fight kidney diseases.
Among the critical areas of cancer research, breast cancer remains a leading concern, and HMGB1 protein is increasingly recognized as a key player in its progression.
HMGB1 (High Mobility Group Box 1) isoforms can be used to explore the mechanisms of several disease models.
All proteins are LPS free, so they are suitable for in vitro and in vivo researches.
Fully reduced HMGB1
All the three cysteines are completely reduced. HMGB1 acts as potent chemoattractant for many cells type. Read more…
Disulfide HMGB1
If two cysteines have a disulfide bond. HMGB1 acts as proinflammatory mediator. Read more…
Terminally oxidized HMGB1
The three cysteines are oxidized to sulfonate. HMGB1 is inactive. Read more…
From our LinkedIn profile
Featured Products
About us
HMGBiotech has R&D and production unit within Ospedale San Raffaele, one of the leading research institutes in Italy as per volume and quality of scientific output. Read more about our company…
